XML 31 R13.htm IDEA: XBRL DOCUMENT
v3.21.1

Stockholders' Equity | 12 Months Ended
--- | ---
Jan. 31, 2021
Stockholders' Equity Note [Abstract] |
STOCKHOLDERS' EQUITY | NOTE 7 - STOCKHOLDERS’ EQUITY COMMON STOCK WARRANTS In fiscal 2020, the Company issued 18,166 warrants to a third party in connection with previous equity raise. These warrants were valued using the Black-Scholes model, with similar assumptions to the June 2018 warrants. The warrants had a fair value of approximately $130,000. Of these warrants, 17,396 were exercised on May 14, 2019. The warrants may be exercised at any time following the date of issuance during the period prior to their expiration date. The fair value of each warrant is estimated on the date of grant using the Black-Scholes model. Expected volatilities are based on the Company’s historical volatility and comparable Companies’ historical volatility for periods when there is not sufficient historical pricing to base the estimate of volatility, which management believes represents the most accurate basis for estimating expected future volatility under the current circumstances. The risk-free rate is based on the U.S. treasury yield in effect at the time of the grant.
|  | May 2019 |
Warrants |  |  | 18,166 |
Expected volatility |  |  | 44 | %
Expected dividend yield |  |  | 0 | %
Expected term (in years) |  |  | 3.00 |
Risk-free interest rate |  |  | 2.69 | %
Exercise price |  | $ | 16.00 |
Calculated fair value of warrant |  | $ | 7.16 |
The following represents warrant activity during fiscal 2021 and 2020:
|  | Average exercise price |  |  | Number of warrants |  |  | Weighted average remaining contractual life (in years) |
Warrants Outstanding at February 3, 2019 |  | $ | 16.83 |  |  |  | 1,067,475 |  |  |  | 2.93 |
Warrants issued |  |  | 16.00 |  |  |  | 18,166 |  |  |  | 2.40 |
Expired and canceled |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | 16.00 |  |  |  | (46,521 | ) |  |  | (2.15 | )
Warrants outstanding at February 2, 2020 |  |  | 16.83 |  |  |  | 1,039,120 |  |  |  | 1.93 |
Warrants issued |  |  | - |  |  |  | - |  |  |  | - |
Expired and canceled |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | 16.00 |  |  |  | (745,147 | ) |  |  | (0.41 | )
Outstanding at January 31, 2021 |  | $ | 19.07 |  |  |  | 293,973 |  |  |  | 2.57 |
In fiscal 2021, 738,897 warrants exercised were cashless, whereby the holders received fewer shares of common stock in lieu of a cash payment to the Company. Warrants exercised in fiscal 2021resulted in the issuance of 439,447 common shares. Warrants exercised in fiscal 2020 resulted in the issuance of 27,246 common shares. EQUITY INCENTIVE PLANS The Company adopted the 2017 Equity Plan which provides for Awards in the form of Options, Stock Appreciation rights, Restricted Stock Awards, Restricted Stock Units, Performance shares, Performance Units, Cash-Based Awards and Other Stock-Based Awards. All awards shall be granted within 10 years from the effective date of the Plan. On June 5, 2019, the stockholders approved an amendment and restatement of the 2017 Equity Plan that among other things increased the number of shares of common stock reserved for issuance from 615,066 to 1,414,889 share of common stock. In June 2019, the Company granted 495,366 Non statutory Stock options to certain officers of the Company with an option price of $38.10 per share. 100% of the stock options are subject to vesting on the first trading day after the date on which the closing price of the Company’s stock price has been at least $75 for 60 consecutive trading days so long as this goal has been attained by June 5, 2022 or the options will terminate. These options were valued using a Monte Carlo simulation model to account for the path dependent market conditions that stipulate when and whether or not the options shall vest. The 495,366 stock options were modified to extend the term of the options through June 5, 2024. This resulted in additional compensation of approximately $874,000, of which, $315,000 was recorded upon modification and the remaining expense was recognized over the remaining expected term. In December 2019, SAC LLC distributed the shares of the Company’s common stock it held. In connection with the distribution officers of the Company agreed to exchange and modify options that were held at SAC LLC for shares of vested common stock of the Company. Pursuant to the exchange SAC LLC transferred 175,478 shares of common stock to the Company and the Company immediately cancelled these shares. The Company then issued to the former option holders the number of those shares pursuant to the 2017 Equity Plan and withheld 73,507 shares to satisfy taxes associated with the issuance. In June 2020, the stockholders of the Company approved an amendment to the 2017 Equity Plan that increased the number of shares of common stock reserved for issuance under the 2017 Equity Plan by 690,000 shares of common stock. The number of shares of common stock reserved for issuance under the 2017 Equity Plan increased from 1,414,889 to 2,104,889 shares of common stock. A summary of the status of our stock options as of January 31, 2021 and February 2, 2020, and changes during fiscal years then ended, is presented below:
|  | For the years ended January 31, 2021 and February 2, 2020 |
|  | Number of options |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual life (in years) |  |  | Average intrinsic value |
Outstanding at February 3, 2019 |  |  | - |  |  | $ | - |  |  |  | - |  |  |  | - |
Granted |  |  | 495,366 |  |  |  | 38.10 |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Expired and canceled |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Vested |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Outstanding at February 2, 2020 |  |  | 495,366 |  |  | $ | 38.10 |  |  |  | 2.34 |  |  |  | - |
Granted |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Expired and canceled |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Vested |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Outstanding at January 31, 2021 |  |  | 495,366 |  |  | $ | 38.10 |  |  |  | 3.35 |  |  |  | - |
Exercisable at the end of the period |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
A summary of the status of our unvested restricted stock units as of January 31, 2021 and February 2, 2020, and changes during fiscal years then ended, is presented below:
|  | Number of shares |  |  | Weighted average grant date fair value |
Unvested at February 3, 2019 |  |  | 377,286 |  |  | $ | 11.16 |
Granted |  |  | 130,898 |  |  |  | 23.63 |
Forfeited |  |  | (20,470 | ) |  |  | 16.21 |
Vested |  |  | (304,661 | ) |  |  | 12.75 |
Unvested at February 2, 2020 |  |  | 183,053 |  |  |  | 21.34 |
Granted |  |  | 627,940 |  |  |  | 16.94 |
Forfeited |  |  | (5,701 | ) |  |  | 11.86 |
Vested |  |  | (149,734 | ) |  |  | 16.24 |
Unvested at January 31, 2021 |  |  | 655,558 |  |  | $ | 18.86 |
Equity-based compensation expense was approximately $4.7 and $4.9 million for fiscal 2021 and 2020, respectively. In fiscal 2020, all the unvested restricted stock units for certain senior executives of the Company that were granted prior to the accelerated vesting trigger, vested according to the accelerated vesting trigger in their restricted stock unit agreements. The triggering event was the market capitalization of the Company post-IPO, exceeding $300 million for 60 consecutive trading days and the expiration of the lock-up period. This accelerated vesting resulted in equity based compensation in the amount of $2.9 million. In December 2019, the exchange and modification of options that were held at SAC LLC resulted in approximately $313,000 of equity-based compensation expense. The total unrecognized equity based compensation cost related to unvested stock option and restricted unit awards was approximately $5.3 million as of January 31, 2021 and will be recognized in operations over a weighted average period of 2.65 years.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration